The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis

IMPORTANCE: A number of officially approved disease-modifying drugs (DMD) are currently available for the early intervention in patients with relapsing-remitting multiple sclerosis (RRMS). The aim of the present study was to systematically evaluate the effect of DMDs on disability progression in RRM...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :PLoS One
Главные авторы: Tsivgoulis, Georgios, Katsanos, Aristeidis H., Grigoriadis, Nikolaos, Hadjigeorgiou, Georgios M., Heliopoulos, Ioannis, Papathanasopoulos, Panagiotis, Kilidireas, Constantinos, Voumvourakis, Konstantinos, Dardiotis, Efthimios
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2015
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4671570/
https://ncbi.nlm.nih.gov/pubmed/26642051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0144538
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы